Spike Health implements 6S management
Release time:
2020-07-22
Peak Health Implementation 6S Management
News In order to further improve the basic management and cultural construction of the enterprise, improve the work quality of all employees, create a good management atmosphere, and create a clean, tidy, comfortable, reasonable and safe working environment and space environment, in the near future, jianfeng Health Technology Company has implemented "6S Management" throughout the factory, namely sorting (SEIRI ), sorting (SEITON ), cleaning (SEISO ), cleaning (SEIKETSU ), literacy (SHITSUKE ) and safety (SECURITY ).
On the basis of participating in the visit and study of the Golden Horse Factory organized by the group company, on the 29th of July , 11 , Jianfeng Health specially organized the workshop and team leaders and backbone 20 people of the enterprise department to visit the Golden Horse Factory to learn and exchange 6S management experience, facilitating employees to gain direct sensory touch and cognitive experience of 6S management. After the visit, Jianfeng Health also collected and sorted out the basic management knowledge of 6S and other enterprises' management standards and detailed rules of 6S in offices, workshops and laboratories, organized targeted study and discussion of employees by classification, and offered suggestions and suggestions in combination with the actual situation of the enterprise, raised awareness and unified thinking, and saw the gap add more motivation.
In order to further do a good job in the management of 6S , Jianfeng Health has also set up a 6S management leading group headed by General Manager Chen Daiyou, and set up three 6S management and implementation groups. Each 6S management implementation working group is responsible for the formulation and implementation of 6S management standards and systems within the responsibility area, and carries out daily management, inspection and assessment. Among them, the office environment 6S management system has specific standards and specifications for basic literacy, documents, books, office desktops (countertops), office chairs, drawers, filing cabinets, computers, printers, fax machines, floors, passageways, walkways, garbage baskets, temporary items, public mobile seats, public health, etc.
At present, Peak Health has carried out 6 factory-wide 6S inspections, completing 102 items and 43 items under continuous rectification. Since the implementation of the 6S management system, the overall environment of peak health has been greatly improved, and the management awareness of the whole staff 6S has been significantly improved. It is understood that Peak Health will continue to promote the management of 6S and develop a good habit of 6S management autonomy through regular and irregular inspections. (Yao Lili)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page